Investor Presentaiton slide image

Investor Presentaiton

III Key Investment Highlights 2 Attractive Industry Dynamics (III/III) A highly defensive sector with significant room for continued growth Pharma Total Market Share Public Sector 3% Market Segmentation | Market Share FY2019 Novartis 8% Pharco 5% GSK 5% Sanofi 5% Amoun 4% Eipico 3% Others 42% Eva 3% Pfizer 3% Hikma 2% Marcyrl 2% Manufacturing FY2018 75 Bn Others 60% Multinational 49% Private Sector 48% Regulated Price 8% ISP 20% Distribution 83 Bn POS 12% UCP 26% Retail 111 Bn Other 69% Hospitals (2.2 k ) & Tenders 23% The distribution space is the most consolidated segment, with the 3 largest players processing 68% of the market sales 25% Industry Regulated Margins Ezaby 2% Seif 1% Roushdy 2% Misr 1% *Distributors operate on a fixed margin set out by the Ministry of Health (MOH), and is marked down from the regulated price of the SKU *In 2016 the distribution margin increased for the 1st time since the 50's from 7% to 8% on locally manufactured products. Also, the retailers margin increased from 20% to 25% Distributors Retailers *Distribution Margin worldwide is between 7 - 12%, Egypt is on the lower side. ibnsinapharma Source: IMS Health, BMI, WHO 14
View entire presentation